Angiotensin II-induced upregulation of AT1 receptor expression: Sequential activation of NF-κB and Elk-1 in neurons

American Journal of Physiology - Cell Physiology

Volumn 299, Issue 3, 2010, Pages

  Mitra, Amit K ^a   Gao, Lie ^a   Zucker, Irving H ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Angiotensin II type 1 receptor; CATH.a; Cell culture; G protein coupled receptors; Small interfering RNA

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR ELK 1; DNA; ELK1 PROTEIN, MOUSE; PARTHENOLIDE; PROTEIN BINDING; SESQUITERPENE; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; CELL LINE; DNA; ETS-DOMAIN PROTEIN ELK-1; MICE; NEURONS; NF-KAPPA B; PROTEIN BINDING; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, SMALL INTERFERING; SESQUITERPENES; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 77956579849     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00127.2010     Document Type: Article

References (33)

1. Blume A, Herdegen T, Unger T. Angiotensin peptides and inducible transcription factors. J Mol Med 77: 339-357, 1999. (Pubitemid 29144070)
2. Dampney RA, Coleman MJ, Fontes MA, Hirooka Y, Horiuchi J, Li YW, Polson JW, Potts PD, Tagawa T. Central mechanisms underlying short- and long-term regulation of the cardiovascular system. Clin Exp Pharmacol Physiol 29: 261-268, 2002.
3. Frantz S, Fraccarollo D, Wagner H, Behr TM, Jung P, Angermann CE, Ertl G, Bauersachs J. Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure. Cardiovasc Res 57: 749-756, 2003.
4. Gaborik Z, Jagadeesh G, Zhang M, Spat A, Catt KJ, Hunyady L. The role of a conserved region of the second intracellular loop in AT1 angiotensin receptor activation and signaling. Endocrinology 144: 2220-2228, 2003.
5. Gaddam KK, Verma A, Thompson M, Amin R, Ventura H. Hypertension and cardiac failure in its various forms. Med Clin North Am 93: 665-680, 2009.
6. Gao L, Li Y, Schultz HD, Wang WZ, Wang W, Finch M, Smith LM, Zucker IH. Downregulated Kv4.3 expression in the RVLM as a potential mechanism for sympathoexcitation in rats with chronic heart failure. Am J Physiol Heart Circ Physiol 298: H945-H955, 2010.
7. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ Res 95: 937-944, 2004.
8. Gao L, Wang WZ, Wang W, Zucker IH. Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: potential mechanism for sympathetic overactivity in heart failure. Hypertension 52: 708-714, 2008.
9. Gohlke P, Ganten D, Lang RE, Unger T. [The renin-angiotensin system: systemic and local function]. Z Kardiol 77 Suppl 3: 1-12, 1988.
10. Kalra D, Sivasubramanian N, Mann DL. Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway. Circulation 105: 2198-2205, 2002. (Pubitemid 34517165)
11. Kang YM, Ma Y, Elks C, Zheng JP, Yang ZM, Francis J. Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-kappaB. Cardiovasc Res 79: 671-678, 2008.
12. Kang YM, Ma Y, Zheng JP, Elks C, Sriramula S, Yang ZM, Francis J. Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension. Cardiovasc Res 82: 503-512, 2009.
13. Karin M, Takahashi T, Kapahi P, Delhase M, Chen Y, Makris C, Rothwarf D, Baud V, Natoli G, Guido F, Li N. Oxidative stress and gene expression: the AP-1 and NF-kappaB connections. Biofactors 15: 87-89, 2001.
14. Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 144: 2179-2183, 2003.
15. Lenkei Z, Palkovits M, Corvol P, Llorens-Cortes C. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol 18: 383-439, 1997.
16. Li J, Brasier AR. Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 10: 252-264, 1996. (Pubitemid 126422952)
17. 2- production, vascular tone, and mitogen-activated protein kinase activation. Circulation 109: 1307-1313, 2004.
18. Li Y, Hou LX, Aktiv A, Dahlstrom A. Studies of the central nervous system-derived CAD cell line, a suitable model for intraneuronal transport studies? J Neurosci Res 85: 2601-2609, 2007.
19. Liu D, Gao L, Roy SK, Cornish KG, Zucker IH. Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase. Circ Res 99: 1004-1011, 2006.
20. Liu D, Gao L, Roy SK, Cornish KG, Zucker IH. Role of oxidant stress on AT1 receptor expression in neurons of rabbits with heart failure and in cultured neurons. Circ Res 103: 186-193, 2008.
21. Mariappan N, Elks CM, Sriramula S, Guggilam A, Liu Z, Borkhsenious O, Francis J. NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res 85: 473-483, 2010.
22. Okada H, Inoue T, Kikuta T, Watanabe Y, Kanno Y, Ban S, Sugaya T, Horiuchi M, Suzuki H. A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade. Am J Pathol 169: 1577-1589, 2006. (Pubitemid 351181990)
23. O'Neill LA, Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20: 252-258, 1997.
24. Schmeisser A, Soehnlein O, Illmer T, Lorenz HM, Eskafi S, Roerick O, Gabler C, Strasser R, Daniel WG, Garlichs CD. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression. Biochem Biophys Res Commun 325: 532-540, 2004. (Pubitemid 39458027)
25. Sriramula S, Haque M, Majid DS, Francis J. Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 51: 1345-1351, 2008.
26. Stefano L, Al SJ, Rossler OG, Vinson C, Thiel G. Up-regulation of tyrosine hydroxylase gene transcription by tetradecanoylphorbol acetate is mediated by the transcription factors Ets-like protein-1 (Elk-1) and Egr-1. J Neurochem 97: 92-104, 2006.
27. Swanson DJ, Zellmer E, Lewis EJ. AP1 proteins mediate the cAMP response of the dopamine beta-hydroxylase gene. J Biol Chem 273: 24065-24074, 1998.
28. 1 receptor and ACE densities after myocardial infarct in rats. Am J Physiol Heart Circ Physiol 286: H1665-H1671, 2004.
29. Toone WM, Morgan BA, Jones N. Redox control of AP-1-like factors in yeast and beyond. Oncogene 20: 2336-2346, 2001.
30. Vanhoutte P, Barnier JV, Guibert B, Pages C, Besson MJ, Hipskind RA, Caboche J. Glutamate induces phosphorylation of Elk-1 and CREB, along with c-fos activation, via an extracellular signal-regulated kinase-dependent pathway in brain slices. Mol Cell Biol 19: 136-146, 1999. (Pubitemid 29018416)
31. 1 receptors in heart failure. Am J Physiol Heart Circ Physiol 295: H1216-H1226, 2008.
32. Zhuo J, Moeller I, Jenkins T, Chai SY, Allen AM, Ohishi M, Mendelsohn FA. Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors. J Hypertens 16: 2027-2037, 1998.
33. Zucker IH, Schultz HD, Patel KP, Wang W, Gao L. Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure. Am J Physiol Heart Circ Physiol 297: H1557-H1566, 2009.